BioHarvest Sciences Inc. Common Stock
NASDAQ:BHSTAgricultural Inputs
+$0.08 today
- Market cap
- $50.25M
- Beta
- 1.33
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$0.50
Volume 0.01M
Average 0.03M
BHST Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
BioHarvest Sciences Inc. Common StockNASDAQ: BHST
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables dips below year-ago levels
Q1 FY2026 accounts receivables of $274K (cash outflow) fell 34.6% year over year, behind the +22.6% change in trailing-twelve-month accounts receivables. Sequentially, it fell 42.6% from the prior quarter. Over 3 fiscal years it compounded at +23.4% a year.
Context
- Accounts receivables amounted to 3.2% of revenue in FY2025, up 0.8 pp from a year earlier.
- Accounts receivables grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -34.6% toward the trailing-twelve-month pace of +22.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (1.11M) USD
- Year-over-year change
- -86.0%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.11M) | -86.0% |
| FY2024 | 2024-12-31 | (594K) | -2600.0% |
| FY2023 | 2023-12-31 | (22K) | +96.3% |
| FY2022 | 2022-12-31 | (588K) | -121.1% |
| FY2021 | 2021-12-31 | (266K) | — |
Accounts Receivables vs competitors
How BHST compares with its peers on the latest reported figures
- BHST's LTM Mar 2026 accounts receivables of $969.56K is the 8th largest of the 9 companies compared; the peer median is $4.08M.
- Its year-over-year change of +22.6% is the 4th highest of 8, against a peer median of -129.7%.
- Accounts receivables amounts to 2.8% of revenue for BHST, versus a peer median of 3.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $37.35M | +151.8% | — | 2.0% | |
| LTM Mar 2026 | $19.33M | +13046.9% | +16.3% | 3.0% | |
| LTM Mar 2026 | $18.29M | -213.1% | — | 3.5% | |
| LTM Mar 2026 | $16.75M | -601.5% | -57.1% | 6.2% | |
| LTM Mar 2026 | $5.44M | -129.7% | +57.9% | 4.9% | |
| LTM Mar 2026 | $2.73M | -212.1% | +113.7% | 3.6% | |
| LTM May 2025 | $1.86M | +2455.5% | — | 3.5% | |
| LTM Mar 2026 | $969.56K | +22.6% | +23.4% | 2.8% | |
USGOU.S. GoldMining Inc. | LTM Feb 2026 | $7.82K | — | — | — |
| Peer median (excluding BHST) | $4.08M | -129.7% | +37.1% | 3.5% | |
Competitors are the stored peer set for BHST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (9.83M) | (11.24M) | (12.56M) | (12.91M) | (11.14M) |
| Depreciation & Amortization | 385.58K | 712K | 840K | 1.25M | 1.62M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 3.37M | 1.35M | 563K | 601K | 597K |
| Change in Working Capital | (96K) | (308K) | 755K | (555K) | (1.94M) |
| Accounts Receivables | (266K) | (588K) | (22K) | (594K) | (1.11M) |
| Inventory | (828K) | (450K) | (1.09M) | (1.19M) | (904K) |
| Accounts Payables | 0 | 730K | 0 | 1.04M | 0 |
| Other Working Capital | 998K | 0 | 1.87M | 188K | 67K |
| Other Non-Cash Items | (627K) | 239K | 1.88M | 4.93M | 3.63M |
| Operating Cash Flow | (6.79M) | (9.24M) | (8.52M) | (6.68M) | (7.23M) |
| Capital Expenditures | (1.64M) | (1.26M) | (1.47M) | (2.84M) | (2.36M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | (192K) | (10K) |
| Investing Cash Flow | (1.64M) | (1.26M) | (1.47M) | (3.03M) | (2.37M) |
| Debt Repayment | (332K) | 7.3M | 13.15M | 2.04M | 5.25M |
| Common Stock Issued | 7.47M | 877K | 534.17K | 4.33M | 25.1M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.64M | (38K) | (131.17K) | 408K | (159K) |
| Financing Cash Flow | 10.77M | 8.14M | 13.56M | 6.78M | 30.19M |
| Effect of Forex Changes | (4K) | (22K) | 59K | (34K) | 39K |
| Net Change in Cash | 2.33M | (2.38M) | 3.62M | (2.97M) | 20.64M |
| Free Cash Flow | (8.43M) | (10.5M) | (10M) | (9.52M) | (9.58M) |
BioHarvest Sciences Inc. Common Stock
NASDAQ:BHST
Intrinsic Alpha fair value
Locked
Current Price
$2.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.